These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10672719)

  • 41. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
    Plouin PF
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
    [No Abstract]   [Full Text] [Related]  

  • 42. [High dose sartan plus diuretic. More power in hypertension and its sequelae].
    MMW Fortschr Med; 2003 Mar; 145(11):59. PubMed ID: 12688201
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of combined therapy with enalapril maleate and hypothiazide on the structuro-functional status of erythrocyte membranes in hypertensive patients].
    Kuriato AV; Geĭchenko VP
    Ter Arkh; 2003; 75(1):45-8. PubMed ID: 12652956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time course of vascular structural changes during and after short-term antihypertensive treatment.
    Hale TM; Shoichet MJ; Bushfield TL; Adams MA
    Hypertension; 2003 Aug; 42(2):171-6. PubMed ID: 12810756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin converting enzyme inhibitors, thiazide diuretics and magnesium balance. A preliminary study.
    Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
    Magnes Res; 1990 Sep; 3(3):193-6. PubMed ID: 2132750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
    Philipp T; Letzel H; Arens HJ
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S67-8. PubMed ID: 9331013
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chronological structure of arterial pressure in hypertensive patients on enalapril].
    Gapon LI; Gubin DG; Semukhin EN; Gubin GD
    Klin Med (Mosk); 2001; 79(3):56-9. PubMed ID: 11490421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The novel method for selection of preparations for treatment of arterial hypertension based on spectral analysis of heart rhythm variability].
    Fleĭshman AN; Filimonov SN; Klimina NV
    Ter Arkh; 2001; 73(12):33-9. PubMed ID: 11858105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effect of enalapril and metoprolol on renal function, potassium balance, lipid profile, cardiac function, exercise tolerance and quality of life in hypertensive dialysis patients.
    Wong KC; Woo KS; Lam WK; Li KT; Lai KN; Nicholls MG; Lui SF
    Int J Artif Organs; 1995 Dec; 18(12):757-62. PubMed ID: 8964641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Lethal polypharmacy in a patient with arterial hypertension].
    Joerger M; Diethelm M
    Dtsch Med Wochenschr; 2004 Dec; 129(50):2714-6. PubMed ID: 15592972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of beta-blockers on the cardiac rhythm variability in patients with hypertension].
    Bil'chenko AV
    Lik Sprava; 2002; (1):38-41. PubMed ID: 11944376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mental changes in hypertensive patients during long-term ambulatory treatment].
    Volkov VS; Tsikulin AE
    Kardiologiia; 1983 Aug; 23(8):30-3. PubMed ID: 6620833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of losartan on cardiac rhythm variability in patients with arterial hypertension].
    Kamenskaia EP
    Lik Sprava; 1999 Sep; (6):117-9. PubMed ID: 10626462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The morphometric characteristics of the erythrocytes and their catecholamine-binding properties in the treatment of stage-II hypertension patients with Renitec].
    Vizir AD; Ostrovskaia SV
    Lik Sprava; 2000; (5):117-21. PubMed ID: 11031471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of enalapril on parasympathetic activity.
    Boni E; Alicandri C; Fariello R; Zaninelli A; Cantalamessa A; Corda L; Muiesan G
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):265-8. PubMed ID: 2285619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The study of organoprotective properties of enalapril in the treatment of arterial hypertension persisting after delivery].
    Tkacheva ON; Barabashkina AV; Razguliaeva NF
    Kardiologiia; 2006; 46(3):39-42. PubMed ID: 16710254
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of chronic angiotensin converting enzyme inhibition on circulating prolactin in systemic hypertension.
    Haznedaroğlu IC; Tokgözoğlu L; Cağlar M; Kes S; Bekdik CF; Kabakçi G; Yörükan S; Uğurlu S
    Horm Metab Res; 1994 Oct; 26(10):491-3. PubMed ID: 7851876
    [No Abstract]   [Full Text] [Related]  

  • 60. Adverse effects using combined rate-slowing antihypertensive agents.
    Handler J
    J Clin Hypertens (Greenwich); 2011 Jul; 13(7):529-32. PubMed ID: 21762367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.